|
Delayed
Nasdaq
15:31:53 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.140 USD | -0.70% |
|
-4.59% | -69.55% |
| Market Cap | 36.49M 31.39M 29.46M 26.95M 50.31M 3.45B 50.7M 348M 136M 1.76B 137M 134M 5.68B | P/E 2024 |
-0.07x | P/E 2025 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 18.67M 16.07M 15.08M 13.79M 25.74M 1.77B 25.95M 178M 69.46M 902M 70.12M 68.59M 2.91B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
96.45% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAZ | Delayed | |
CBOE
| RNAZ | Real-time |
Last Transcript : TransCode Therapeutics, Inc.
| 1 day | -3.48% | ||
| 1 week | -4.59% | ||
| Current month | -0.95% | ||
| 1 month | -53.26% | ||
| 3 months | -64.38% | ||
| 6 months | -78.86% | ||
| Current year | -69.55% |
| 1 week | 1.83 |  | 2.35 |
| 1 month | 1.83 | | 4.54 |
| Current year | 1.83 | | 12.6 |
| 1 year | 1.83 | | 20.99 |
| 3 years | 1.83 | | 118,271.9 |
| 5 years | 1.83 | | 3,901,981.08 |
| 10 years | 1.83 | | 5,174,452.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Calais
CEO | Chief Executive Officer | 67 | 05/10/2025 |
Zdravka Medarova
CTO | Chief Tech/Sci/R&D Officer | 52 | 30/09/2021 |
| Chief Executive Officer | 75 | 12/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 30/06/2018 | |
Philippe Calais
CHM | Chairman | 67 | 17/02/2021 |
Erik Manting
BRD | Director/Board Member | 54 | 19/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/08/26 | Conversion | Company | 13,834,441 | 81.7120% | ||
| 27/07/26 | Other | Company | 300,040 | 1.7722% | ||
| 14/06/24 | Free | Director | 70,000 | 1.0654% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.70% | -4.59% | -80.19% | -100.00% | 36.49M | |
| +0.41% | -2.07% | +41.26% | +95.40% | 69.02B | |
| -1.97% | -0.02% | +41.75% | +88.46% | 66.32B | |
| -0.14% | +7.11% | -10.92% | +381.49% | 27.66B | |
| +0.85% | +1.32% | -0.08% | -15.23% | 25.84B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 26.54B | |
| -0.86% | +0.88% | +24.64% | -18.33% | 20.4B | |
| +3.45% | -13.46% | +222.69% | +389.50% | 17.63B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 15.15B | |
| -0.65% | +7.68% | +56.85% | +163.27% | 14.65B | |
| Average | -0.67% | -1.78% | +33.50% | +152.42% | 28.33B | |
| Weighted average by Cap. | -0.52% | -0.83% | +40.99% | +140.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -16.75M -14.42M -13.53M -12.38M -23.1M -1.58B -23.28M -160M -62.32M -809M -62.92M -61.55M -2.61B | -34.66M -29.82M -27.99M -25.6M -47.79M -3.28B -48.17M -331M -129M -1.67B -130M -127M -5.39B |
| Net Debt | -5.77M -4.97M -4.66M -4.26M -7.96M -546M -8.02M -55.14M -21.47M -279M -21.68M -21.21M -898M | -17.81M -15.33M -14.38M -13.16M -24.56M -1.68B -24.76M -170M -66.26M -861M -66.89M -65.43M -2.77B |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$2.140 | -0.70% | 3,463 |
| 03/09/26 | US$2.155 | +7.21% | 69,966 |
| 02/09/26 | US$2.010 | -2.43% | 22,514 |
| 01/09/26 | US$2.060 | -1.90% | 98,170 |
| 31/08/26 | US$2.100 | -3.67% | 838,250 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- RNAZ Stock
Select your edition
All financial news and data tailored to specific country editions
